JAMP SPIRONOLACTONE
JAMP SPIRONOLACTONE
Approved
DIN Number
02518848
Drug Class
Human
Market Date
Jul 14, 2022
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02518848
AIG Number0106462002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03DA01 SPIRONOLACTONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
SPIRONOLACTONEActive
Strength: 100 MG
Monograph: SPIRONOLACTONE